Magnesium is one of 168 small molecule programs targeting Low back pain. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
116 competitors in Ischemic Stroke
Tnkase
Ozempic
Magnesium
Atorvastatin Calcium
Butylphthalide
PCSK9 Inhibitor
Edaravone Dexborneol
SGLT-2 Inhibitors
Y-6
Proamatine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details